Literature DB >> 21848895

Postoperative morbidity after fast-track laparoscopic resection of rectal cancer.

S Stottmeier1, H Harling, P Wille-Jørgensen, L Balleby, H Kehlet.   

Abstract

AIM: Analysis was carried out of the nature and chronological order of early complications after fast-track laparoscopic rectal surgery with a view to optimizing the short-time outcome of rectal cancer surgery.
METHOD: A total of 102 consecutive patients who underwent elective fast-track laparoscopic rectal cancer surgery were analysed prospectively from the Danish Colorectal Cancer Database supplemented by data from the medical records. We studied in detail the nature and chronological order of postoperative morbidity and reason for prolonged stay (> 5 days).
RESULTS: Twenty-five patients (25%) had one or more complications. Surgical complications occurred in 19 patients, while six patients had medical complications as the primary event. Fifteen patients underwent reoperation, three died, and eight were readmitted within 30 days. The median length of stay was 5 days (range 2-42).
CONCLUSION: Postoperative morbidity remains a significant problem in the fast-track era, even in experienced surgical hands. Our results suggest that besides improvement of surgical technique further improvement of outcome lies in early recognition and proper treatment of complications and the perioperative optimization of organ function.
© 2011 The Authors. Colorectal Disease © 2011 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Mesh:

Year:  2012        PMID: 21848895     DOI: 10.1111/j.1463-1318.2011.02767.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  8 in total

1.  Factors associated with failure of enhanced recovery programs after laparoscopic colon cancer surgery: a single-center retrospective study.

Authors:  Heung-Kwon Oh; Myong Hun Ihn; Il Tae Son; Jin Taek Park; Jaebong Lee; Duck-Woo Kim; Sung-Bum Kang
Journal:  Surg Endosc       Date:  2015-08-04       Impact factor: 4.584

2.  Enhanced recovery after surgery (ERAS) pathway vs traditional care in laparoscopic rectal resection: a single-center experience.

Authors:  A Vignali; U Elmore; A Cossu; M Lemma; B Calì; P de Nardi; R Rosati
Journal:  Tech Coloproctol       Date:  2016-06-04       Impact factor: 3.781

3.  Newly implemented enhanced recovery pathway positively impacts hospital length of stay.

Authors:  Thomas D Martin; Talya Lorenz; Jane Ferraro; Kevin Chagin; Richard M Lampman; Karen L Emery; Joan E Zurkan; Jami L Boyd; Karin Montgomery; Rachel E Lang; James F Vandewarker; Robert K Cleary
Journal:  Surg Endosc       Date:  2015-12-22       Impact factor: 4.584

4.  Impact of fast-track care program in laparoscopic rectal cancer surgery: a cohort-comparative study.

Authors:  Hélène Meillat; Victor Serenon; Clément Brun; Cécile de Chaisemartin; Marion Faucher; Bernard Lelong
Journal:  Surg Endosc       Date:  2022-04-04       Impact factor: 3.453

5.  Early rehabilitation versus conventional care after laparoscopic rectal surgery: a prospective, randomized, controlled trial.

Authors:  Sung-Min Lee; Sung-Bum Kang; Je-Ho Jang; Jun-Seok Park; Samin Hong; Taek-Gu Lee; Soyeon Ahn
Journal:  Surg Endosc       Date:  2013-05-25       Impact factor: 4.584

Review 6.  Early rehabilitation programs after laparoscopic colorectal surgery: evidence and criticism.

Authors:  Duck-Woo Kim; Sung-Bum Kang; Soo-Young Lee; Heung-Kwon Oh; Myung-Hoon In
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

Review 7.  Systematic review and meta-analysis for laparoscopic versus open colon surgery with or without an ERAS programme.

Authors:  W R Spanjersberg; J D P van Sambeeck; A Bremers; C Rosman; C J H M van Laarhoven
Journal:  Surg Endosc       Date:  2015-03-24       Impact factor: 4.584

8.  The implementation of a standardized approach to laparoscopic rectal surgery.

Authors:  Katrine Kanstrup Aslak; Orhan Bulut
Journal:  JSLS       Date:  2012 Apr-Jun       Impact factor: 2.172

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.